Cerca

comunicati

MeRes100 BRS - the World's First Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffold - Shows Consistent Long-term Positive Safety With Consistent Low MACE Rates and Zero Scaffold Stent Thrombosis for Patients With Coronary Artery Disease

12 Luglio 2019

0

Condividi le tue opinioni su Libero Quotidiano

Caratteri rimanenti: 400

media